drugset
drugset / Trial / NCT04704232

Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers

NCT04704232 ↗

Phase 1 Completed 24 enrolled AlzeCure Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase 1 b placebo-controlled study in healthy volunteers to study safety, efficacy and pharmacokinetics of Topical ACD440 on normal skin, skin optimized for penetration and skin exposed to ultraviolet radiation

Timeline

Start
2021-01-12
Primary completion
2021-03-10
Completion
2021-03-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator ACD440 Unknown — Topical

Indications

No indication recorded.